Advantis Medical Imaging Receives FDA Clearance for Brain MRI Analysis Software

Advantis Medical Imaging, a pioneering manufacturer of cloud-based medical imaging software solutions, today announced its first 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance is for Brainance MD™, a groundbreaking and all-in-one neuroimaging platform for the analysis of brain MRI exams.

Accessible from a web browser, Brainance MD™ is designed to enable the display,  processing, and analysis of brain MR images, including diffusion tensor imaging (DTI), dynamic susceptibility contrast (DSC) perfusion, and functional MRI (fMRI) – all in a unified and highly intuitive user interface. The fully DICOM compliant application is provided as a Software as a Service (SaaS) and offers analysis and visualization capabilities of dynamic MRI data of the brain, presenting the results in a clinically useful context and further assisting clinicians during the diagnostic workflow of brain MRI exams.

“Advanced brain MRI processing techniques which were previously regarded as more research-oriented due to their scientific complexity and time-consuming manual processing needs are now available to clinicians in an all-in-one, automated and highly intuitive software.” said Zoi Giavri, CEO & CSO. “Our solution eliminates any unnecessary manual work, embraces remote access and collaborative exam review, enhances standardisation and reduces operating overhead for clinical organizations through its zero-footprint nature and optimized processing pipelines.”

“Today’s modern radiology departments are in constant search of highly reliable, automation-driven and user-friendly software tools which can alleviate their rapidly growing workloads and assist them in focusing more on clinical findings.” said Paris Ziogkas, COO & Head of Business Development. “This FDA clearance is a pivotal milestone for our company and marks the beginning of a series of product development announcements as we are expanding to other human organs aiming to offer a more holistic imaging suite, which covers a wide spectrum of medical image processing needs and pathologies.”

Brainance MD™ is currently in use in Europe as a CE Marked device where numerous clinical organizations have integrated it in their daily clinical brain MRI processing workflows.  With this first FDA clearance the company aims to collaborate with U.S. clinicians by assisting them to focus on clinical findings and save valuable time.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version